Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
FWOSB79: A novel cancer therapy that selectively targets tumor-infiltrating regulatory T cells
Van Ginderachter, J. (Administrative Promotor), Laoui, D. (Co-Promotor) & Arnouk, S. (Mandate)
1/11/19 → 31/10/23
Project: Fundamental
-
The Regulation and Role of Lipid-Laden GPNMB+ Tumor-Associated Macrophages in Non-Small Cell Lung Carcinoma
Rolain, I., Van Craenenbroeck, J., Arnouk, S., Swinnen, J. (Contributor), Laoui, D. & Van Ginderachter, J., 2026, (Unpublished). 1 p.Research output: Unpublished contribution to conference › Poster
-
Anti-MIF nanobody therapy potentiates anti-PD1 treatment by enhancing anti-tumor immunity in a pre-clinical colorectal cancer model
Mora Barthelmess, R., Lage Marques, B. (Contributor), Zivalj, M. (Contributor), Van Craenenbroeck, J. (Contributor), Jumapili, A. N. (Contributor), Vincke, C. (Contributor), Hadadi, E. (Contributor), Arnouk, S. (Contributor), Stijlemans, B. & Van Ginderachter, J., 2025, (Unpublished).Research output: Unpublished contribution to conference › Poster
-
Anti-MIF Nbs, a novel tool
Mora Barthelmess, R., Zivalj, M. (Contributor), Lage Marques, B. (Contributor), Van Craenenbroeck, J. (Contributor), Jumapili, A. N. (Contributor), Vincke, C. (Contributor), Arnouk, S. (Contributor), Hadadi, E. (Contributor), Stijlemans, B. & Van Ginderachter, J., 26 Apr 2025.Research output: Unpublished contribution to conference › Poster
-
Characterization and validation of Lipocalin-2-targeting Nanobodies with application potential across various disease models
Zivalj, M., Vincke, C. (Contributor), Sánchez-Bayuela, T. (Contributor), Romao, E. (Contributor), Destrijcker, R. (Contributor), Ahmed, D. T. A. A. (Contributor), Mehmeti, N. (Contributor), Gupta, M. S. (Contributor), Schoonooghe, S. (Contributor), Hassanzadeh Ghassabeh, G. (Contributor), Arnouk, S. (Contributor), Raes, G. (Contributor), Jaisser, F. (Contributor), Sterckx, Y.G.-J. (Contributor), Van Ginderachter, J. (Contributor) & Stijlemans, B., 2025.Research output: Unpublished contribution to conference › Poster
-
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD1 Immunotherapy
Arnouk, S. M., Kancheva, D., Van Damme, H., Courtoy, G. E., Mora Barthelmess, R., Van Craenenbroeck, J., Lebegge, E., Elkrim, Y., Assaf, N., Heremans, Y., Murgaski, A., De Groof, T. W. M., Clappaert, E., Debraekeleer, A., Brughmans, J., Blancke, G., Kiss, M., Forsyth, R., Waelput, W. & Boon, L. & 9 others, , 1 Dec 2025, In: Cancer Research. 85, 23, p. 4681-4700 20 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Citations (Scopus)98 Downloads (Pure)
Datasets
-
Dataset related to article "Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting"
Movahedi, K. (Creator), Allavena, P. (Creator), Erreni, M. (Creator), Debie, P. (Creator), Mantovani, A. (Creator), D'Autilia, F. (Creator), Doni, A. (Creator), van Leeuwen, F. W. B. (Creator), Avigni, R. (Creator), Arnouk, S. M. (Creator), Vincke, C. (Creator), Van Ginderachter, J. (Creator), Anselmo, A. (Creator), Parente, R. (Creator), Hernot, S. (Creator), Garlanda, C. (Creator) & Bolli, E. (Creator), Zenodo, 4 Dec 2023
DOI: 10.5281/zenodo.10254683, https://zenodo.org/records/10254683
Dataset
Activities
- 4 Talk or presentation at a conference
-
GPNMB+ Tumor-Associated Macrophages Exhibit Elevated Lipid Metabolism and Immunosuppressive Phenotype in NSCLC
Van Craenenbroeck, J. (Speaker), Arnouk, S. (Contributor), Raes, G. (Contributor), Van Ginderachter, J. (Contributor), Swinnen, J. V. (Contributor), Mora Barthelmess, R. (Contributor), Jumapili, A. N. (Contributor) & Zivalj, M. (Speaker)
Oct 2025Activity: Talk or presentation › Talk or presentation at a conference
-
GPNMB+ Tumor-Associated Macrophages Exhibit Elevated Lipid Metabolism and Immunosuppressive Phenotype in NSCLC
Van Craenenbroeck, J. (Speaker), Arnouk, S. (Contributor), Raes, G. (Contributor), Van Ginderachter, J. (Contributor), Swinnen, J. V. (Contributor), Mora Barthelmess, R. (Contributor), Jumapili, A. N. (Contributor) & Zivalj, M. (Speaker)
Oct 2025Activity: Talk or presentation › Talk or presentation at a conference
-
Tumor-derived cDC therapy to prevent relapse and metastasis in NSCLC
Marcq, E. (Speaker), Allonsius, L. (Contributor), Murgaski, A. (Contributor), Arnouk, S. (Contributor), Caro, A. A. (Contributor), Kancheva, D. (Contributor), Elkrim, Y. (Contributor), Brughmans, J. (Contributor), Debraekeleer, A. (Contributor), Mayet, A. Y. (Contributor), Boon, L. (Contributor), Schmittnaegel, M. (Contributor), Hadadi, E. (Contributor), Kiss, M. (Contributor), Raes, G. (Contributor), Nana, F. A. (Contributor), Ries, C. H. (Contributor), Deschoemaeker, S. (Contributor) & Laoui, D. (Contributor)
29 Sept 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Vaccination with tumor-derived conventional type 2 dendritic cells delays spontaneous lung metastasis
Marcq, E. (Speaker), Allonsius, L. (Contributor), Murgaski, A. (Contributor), Arnouk, S. (Contributor), Caro, A. A. (Contributor), Kancheva, D. (Contributor), Hamouda, A. E. I. (Contributor), Elkrim, Y. (Contributor), Brughmans, J. (Contributor), Debraekeleer, A. (Contributor), Mayet, A. Y. (Contributor), Boon, L. (Contributor), Schmittnaegel, M. (Contributor), Kiss, M. (Contributor), Raes, G. (Contributor), Nana, F. A. (Contributor), Ries, C. H. (Contributor), Deschoemaeker, S. (Contributor), Hadadi, E. (Contributor) & Laoui, D. (Contributor)
19 Oct 2023Activity: Talk or presentation › Talk or presentation at a conference
Thesis
-
Nanobody-based targetting of pro-tumoral tumor-associated marcophages as novel cancer therapy
Arnouk, S. ((PhD) Student) & Ballet, S. (Jury), Van Ginderachter, J. (Promotor), 4 Sept 2018Student thesis: Master's Thesis